Evidence map›Paper›PMID 37935953›Full record

ArticleNPJ digital medicine2023

Quantifying the impact of AI recommendations with explanations on prescription decision making.

Myura Nagendran, Paul Festor, Matthieu Komorowski, Anthony C Gordon, Aldo A Faisal

Open access · goldAbstract read
In one paragraph

Article in NPJ digital medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Myura NagendranUKRI Centre for Doctoral Training in AI for Healthcare, Imperial College London, London, UK.
Paul FestorUKRI Centre for Doctoral Training in AI for Healthcare, Imperial College London, London, UK.
Matthieu KomorowskiDivision of Anaesthetics, Pain Medicine, and Intensive Care, Imperial College London, London, UK.
Anthony C GordonDivision of Anaesthetics, Pain Medicine, and Intensive Care, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-0419-547X
Aldo A FaisalUKRI Centre for Doctoral Training in AI for Healthcare, Imperial College London, London, UK. a.faisal@imperial.ac.uk.ORCID http://orcid.org/0000-0003-0813-7207
Imperial College London · GBImperial College Healthcare NHS Trust · GB

Funding

DH | National Institute for Health Research (NIHR) RP-2015-06-018RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/S023283/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/V025449/1
6 · The paper itself

Abstract

The influence of AI recommendations on physician behaviour remains poorly characterised. We assess how clinicians' decisions may be influenced by additional information more broadly, and how this influence can be modified by either the source of the information (human peers or AI) and the presence or absence of an AI explanation (XAI, here using simple feature importance). We used a modified between-subjects design where intensive care doctors (N = 86) were presented on a computer for each of 16 trials with a patient case and prompted to prescribe continuous values for two drugs. We used a multi-factorial experimental design with four arms, where each clinician experienced all four arms on different subsets of our 24 patients. The four arms were (i) baseline (control), (ii) peer human clinician scenario showing what doses had been prescribed by other doctors, (iii) AI suggestion and (iv) XAI suggestion. We found that additional information (peer, AI or XAI) had a strong influence on prescriptions (significantly for AI, not so for peers) but simple XAI did not have higher influence than AI alone. There was no correlation between attitudes to AI or clinical experience on the AI-supported decisions and nor was there correlation between what doctors self-reported about how useful they found the XAI and whether the XAI actually influenced their prescriptions. Our findings suggest that the marginal impact of simple XAI was low in this setting and we also cast doubt on the utility of self-reports as a valid metric for assessing XAI in clinical experts.

Identifiers

PMID37935953
PMCPMC10630476
OpenAlexW4388452582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.